Assessment and Management of Uncontrolled Type 2 Diabetes in Alicia Rodriguez

QUESTION

Alicia Rodriguez is a 36-year-old woman who presents to the clinic complaining of frequent and burning urination.  She reports having recurrent UTIs and vaginal yeast infections for the past 8 years, ever since the birth of her second child.  She is adherent to her physician appointments every 3 months since she was diagnosed with T2DM 3 years ago.  She is aware that her glucose and A1C are not at goal and she needs to control her diabetes. She walks 3 to 4 days per week for 20 to 30 minutes, depending on the weather.  She denies any feelings of dizziness, lightheadedness, or fatigue.

PMH: Dyslipidemia x 5 years; T2DM x 3 years; Obesity x 20 years; Recurrent UTI and yeast infections x 8 years; Gestational DM in two pregnancies (10 and 8 years ago)

FAMILY HISTORY:  Father had T2DM, dyslipidemia, hypertension and died from a myocardial infarction at age 56.  Mother is alive at age 60 and has T2DM, dyslipidemia, sleep apnea, and GERD. Brother is alive at age 40 and has T2DM and HTN.  Sister is alive at age 33 and is healthy.

SOCIAL HISTORY:    Immigrated from Puerto Rico at age 6, is married for 13 years and lives with her husband and 2 children.  Works as an administrative assistant.  Drinks 1 or 2 glasses of wine 2-3 times a week.  Denies tobacco or illicit drug use.

NKDA

MEDICATIONS:

Aspirin 81 mg daily

Atorvastatin 20 mg at bedtime

Metformin 1000 mg with dinner

Ortho Tricyclen 28 1 daily

Acetaminophen 500 mg prn

VITAL SIGNS:  BP 136/78     Weight: 225.5 lbs    Height:             63 inches Waist:  37 inches

LABS:

Na       137      K         4.7       Cl        101      CO2    22        Sr Cr 0.8         Glu      168

HbA1C           8.2%    Total Chol      184      LDL    112      HDL   29        Trig     217

Questions:

1. What signs and symptoms is the patient experiencing that indicate her DM is not controlled?
2. What diabetes related complications does the patient have?
3. What are the therapeutic goals for this patient?
4. What modifications would you make to her drug therapy and diabetes self-management plans?
5. How should the patient’s therapeutic plan be monitored?

ANSWER

Assessment and Management of Uncontrolled Type 2 Diabetes in Alicia Rodriguez

Introduction

Alicia Rodriguez, a 36-year-old woman, presents with symptoms suggestive of uncontrolled diabetes. As her medical history reveals, she has a history of recurrent urinary tract infections (UTIs), vaginal yeast infections, and suboptimal glucose control. This essay aims to explore the signs and symptoms indicating her uncontrolled diabetes, identify related complications, outline therapeutic goals, propose modifications to her drug therapy and self-management plans, and discuss the necessary monitoring for her therapeutic plan.

Signs and Symptoms of Uncontrolled Diabetes

Frequent and Burning Urination: Alicia’s complaint of frequent and burning urination suggests the possibility of hyperglycemia, which can lead to increased urine production and urinary tract symptoms.

Recurrent UTIs and Vaginal Yeast Infections: Alicia’s history of recurrent UTIs and vaginal yeast infections may be indicative of poor glycemic control. High blood glucose levels create a favorable environment for bacterial and fungal growth, increasing the risk of infections.

Diabetes-Related Complications

Dyslipidemia: Alicia’s history of dyslipidemia suggests the presence of lipid abnormalities commonly associated with uncontrolled diabetes. Elevated triglyceride levels and low HDL cholesterol are concerning in her case.

Obesity: Alicia’s long-standing obesity is a significant risk factor for the development and progression of type 2 diabetes. It exacerbates insulin resistance and contributes to the overall metabolic dysfunction.

Therapeutic Goals

The therapeutic goals for Alicia’s uncontrolled diabetes should focus on achieving and maintaining optimal glycemic control, reducing the risk of complications, and addressing comorbidities. Specific goals may include:

Glycemic Control: Targeting a hemoglobin A1C level of less than 7% is recommended to minimize the risk of microvascular complications.

Weight Management: Implementing lifestyle modifications, including diet and exercise, to achieve weight loss and improve insulin sensitivity.

Blood Pressure and Lipid Control: Addressing dyslipidemia and hypertension to reduce the risk of cardiovascular complications.

Modifications to Drug Therapy and Self-Management Plans

Antidiabetic Medication: Given Alicia’s suboptimal glycemic control, an adjustment in her medication regimen may be necessary. Increasing the dose of metformin, adding or intensifying the use of antihyperglycemic agents such as a dipeptidyl peptidase-4 (DPP-4) inhibitor or a glucagon-like peptide-1 receptor agonist (GLP-1 RA) can be considered.

Diabetes Self-Management: Alicia should receive education on healthy eating, regular physical activity, and self-monitoring of blood glucose levels. Emphasizing the importance of adherence to medication, lifestyle modifications, and self-care practices is crucial for optimal disease management.

Monitoring the Therapeutic Plan

Blood Glucose Monitoring: Regular monitoring of blood glucose levels, both fasting and postprandial, can provide valuable insights into the effectiveness of medication adjustments and lifestyle modifications.

Hemoglobin A1C Testing: Periodic measurement of hemoglobin A1C levels every 3-6 months helps evaluate long-term glycemic control and guides treatment decisions.

Lipid Profile Monitoring: Regular lipid profile assessments are necessary to assess lipid control and guide therapeutic interventions.

Blood Pressure Monitoring: Routine blood pressure measurements assist in assessing and managing hypertension, a common comorbidity in individuals with diabetes.

Conclusion

Alicia Rodriguez’s case highlights the importance of identifying and addressing uncontrolled diabetes through comprehensive management strategies. By recognizing signs and symptoms of poor glycemic control, understanding associated complications, setting appropriate therapeutic goals, modifying drug therapy and self-management plans, and implementing regular monitoring, healthcare providers can improve Alicia’s glycemic control, reduce the risk of complications, and enhance her overall health outcomes.